Our Services
Medical Information
Helpful Resources
Published on: 9/15/2026
Rick Simpson Oil (RSO) is a highly concentrated cannabis extract with very high THC levels, so risks like severe intoxication, dizziness, rapid heartbeat, anxiety, vomiting, and impaired coordination are possible, especially at the large doses often recommended. It can also interact with many common medications, including blood thinners such as warfarin, sedatives and benzodiazepines, opioids, certain antidepressants and antiseizure drugs, and medications processed by liver enzymes (CYP3A4 and CYP2C9), potentially raising or lowering their levels in your blood. Product potency and purity vary widely because RSO is often homemade or unregulated, which adds further risk. There are several important safety factors and drug-specific details to consider, so see below for the complete answer before using RSO alongside your prescriptions.
If you are feeling unwell, unusually drowsy, dizzy, or noticing new symptoms while using RSO or any cannabis product, a free, instant, online symptom check can help you sort out what may be causing it and what to do next, so you can decide whether to adjust course, call a pharmacist, or seek medical care right away.
Last reviewed for medical accuracy: 09/14/2026
Rick Simpson Oil (RSO) is a concentrated cannabis extract named after its creator, Canadian medical marijuana activist Rick Simpson. It’s made by soaking cannabis in a solvent (often ethanol or isopropyl alcohol), then evaporating the liquid to leave behind a thick, dark oil high in THC (tetrahydrocannabinol).
RSO has gained popularity for anecdotal reports of pain relief, reduced inflammation, and even anti-tumor effects. However, because it’s unregulated and highly potent, it’s important to understand potential risks and interactions before use.
Because of its potency and variable composition, RSO can affect people more strongly and unpredictably than standard cannabis products.
Much of the support for RSO comes from personal testimonials rather than large, controlled studies. Here’s what we know so far:
While these potential benefits exist, they apply to cannabis products broadly. Specific data on RSO, which is far more concentrated, remain scarce.
Even when sourced from a licensed producer, RSO carries the risks associated with high-dose THC:
When RSO is made improperly, residual solvents or contaminants (pesticides, heavy metals, mold) can add extra risk. Always check for third-party lab testing if available.
Rick Simpson Oil (RSO) contains THC and other cannabinoids that your body processes through liver enzymes (primarily CYP3A4 and CYP2C9). This creates potential interactions with many prescription and over-the-counter medications.
Key interactions include:
If you’re on any regular medication—especially for the heart, brain, blood, or immune system—talk with your doctor or pharmacist before trying RSO.
Because RSO is largely unregulated, there’s no standardized manufacturing process. Common issues:
If you choose to try RSO, seek products with a certificate of analysis (COA) from a reputable lab. Avoid homemade batches unless produced by someone with extraction experience.
Any of the following warrant immediate medical attention:
For less urgent concerns, consider a free, online symptom check, using the doctor approved Ubie Symptom Checker (https://ubiehealth.com/) to guide your next steps.
Rick Simpson Oil (RSO) is a potent form of cannabis extract with both potential benefits and significant risks. Because it’s unregulated and high in THC:
Always speak to a healthcare professional—especially if you’re taking any medications or have chronic health conditions—before trying RSO. If you encounter any severe or life-threatening symptoms, contact your doctor or local emergency services immediately.
(References)
* Russo EB. Taming THC: potential cannabis synergy and phytocannabinoid-terpenoid entourage effects. Br J Pharmacol. 2011 Aug;163(7):1344-64. doi: 10.1111/j.1476-5381.2011.01238.x. PMID: 21749363; PMCID: PMC3165946.
* MacCallum CA, Russo EB. Practical considerations in medical cannabis administration and dosing. Eur J Intern Med. 2018 Mar;49:12-19. doi: 10.1016/j.ejim.2018.01.004. Epub 2018 Jan 4. PMID: 29307505.
* Lucas CJ, Galettis P, Schneider J. The pharmacokinetics and the pharmacodynamics of cannabinoids. Br J Clin Pharmacol. 2018 Nov;84(11):2477-2482. doi: 10.1111/bcp.13710. Epub 2018 Aug 7. PMID: 30001569; PMCID: PMC6177698.
* Amin MR, Ali DW. Pharmacology of Medical Cannabis. Adv Exp Med Biol. 2019;1162:151-165. doi: 10.1007/978-3-030-21737-2_8. PMID: 31332738.
* Silva EAD Junior, Medeiros WMB, Torro N, Sousa JMM, Almeida IBCM, Costa FBD, Pontes KM, Nunes ELG, Rosa MDD, Albuquerque KLGD. Cannabis and cannabinoid use in autism spectrum disorder: a systematic review. Trends Psychiatry Psychother. 2022 Jun 13;44:e20200149. doi: 10.47626/2237-6089-2020-0149. Epub 2022 Jun 13. PMID: 34043900; PMCID: PMC9887656.
* Silva EAD Junior, Medeiros WMB, Santos JPMD, Sousa JMM, Costa FBD, Pontes KM, Borges TC, Espínola C Neto Segundo, Andrade E Silva AH, Nunes ELG, Alves NT, Rosa MDD, Albuquerque KLGD. Evaluation of the efficacy and safety of cannabidiol-rich cannabis extract in children with autism spectrum disorder: randomized, double-blind, and placebo-controlled clinical trial. Trends Psychiatry Psychother. 2024;46:e20210396. doi: 10.47626/2237-6089-2021-0396. Epub 2022 May 26. PMID: 35617670; PMCID: PMC11332686.
* Lo JO, Hedges JC, Girardi G. Impact of cannabinoids on pregnancy, reproductive health, and offspring outcomes. Am J Obstet Gynecol. 2022 Oct;227(4):571-581. doi: 10.1016/j.ajog.2022.05.056. Epub 2022 May 31. PMID: 35662548; PMCID: PMC9530020.
* Hoch E, Volkow ND, Friemel CM, Lorenzetti V, Freeman TP, Hall W. Cannabis, cannabinoids and health: a review of evidence on risks and medical benefits. Eur Arch Psychiatry Clin Neurosci. 2025 Mar;275(2):281-292. doi: 10.1007/s00406-024-01880-2. Epub 2024 Sep 19. PMID: 39299947; PMCID: PMC11910417.
* Hsu M, Shah A, Jordan A, Gold MS, Hill KP. Therapeutic Use of Cannabis and Cannabinoids: A Review. JAMA. 2026 Jan 27;335(4):345-359. doi: 10.1001/jama.2025.19433. PMID: 41296368.
* Kansagara D, Terry GE, Ayers CK, D'Souza DC. Cannabis and Mental Health: A Review. JAMA Intern Med. 2026 May 1;186(5):618-628. doi: 10.1001/jamainternmed.2025.8215. PMID: 41801216.
We would love to help them too.
For First Time Users
We provide a database of explanations from real doctors on a range of medical topics. Get started by exploring our library of questions and topics you want to learn more about.
Was this page helpful?
Purpose and positioning of servicesUbie Doctor's Note is a service for informational purposes. The provision of information by physicians, medical professionals, etc. is not a medical treatment. If medical treatment is required, please consult your doctor or medical institution. We strive to provide reliable and accurate information, but we do not guarantee the completeness of the content. If you find any errors in the information, please contact us.